Tyra Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Tyra Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.000.000.000.000.00
Gross Profit0.000.000.000.000.00
Operating Expenses
Research & Development80.0862.5243.0120.647.20
Selling, General & Administrative24.1017.4315.925.652.09
Operating Expenses104.1879.9558.9326.299.30
Operating Income-104.18-79.95-58.93-26.29-9.30
Other Income/Expense
Interest Income17.7010.813.650.010.00
Interest Expense0.000.000.000.000.00
Other Income/Expense17.70-0.04-0.05-0.02-0.04
Income
Income Before Tax-86.48-69.13-55.33-26.29-9.34
Income Tax Expense0.000.000.000.000.00
Net Income-86.48-69.13-55.33-26.29-9.34
Net Income - Continuous Operations-86.48-69.13-55.33-26.290.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-103.66-79.59-58.63-26.15-9.25
EBIT-104.18-79.95-58.93-26.29-9.30
Depreciation & Amortization0.520.360.300.140.05
Earnings Per Share
Basic EPS-2.00-2.00-1.00-2.00-6.00
Diluted EPS-2.00-2.00-1.00-2.00-6.00
Basic Shares Outstanding57.2242.7041.8813.781.54
Diluted Shares Outstanding57.2242.7041.8813.781.54